Hemorrhagic Fever, Ebola - 25 Studies Found Completed : Efficacy of Favipiravir Against Ebola (JIKI) : Ebola Virus Disease : 2014-12-16 : Drug: Favipiravir Group A1: Day-0 (inclusion), h0: 2400 mg Withdrawn : Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) : Ebola Virus Disease : 2014-11-21 : Drug: Best Supportive Care Deh Active, not recruiting : Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) : Prevention of Ebola Infection : 2015-07-17 : Biological: V920 Consistency Lot A Recruiting : Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up : Ebola Virus Disease : 2015-04-30 Recruiting : PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response : Ebola Virus Disease : 2017-03-30 <<< Previous